公开(公告)号：US20230337967A1

公开(公告)日：2023-10-26

申请号：US18210489

申请日：2023-06-15

Applicant: Biogen MA Inc.

Inventor： Donald R. Johns ,  Dawei [b2047] Liu ,  Toby Ferguson ,  Jesse M. Cedarbaum

IPC: A61B5/00 ,  A61B5/11 ,  A61B5/145 ,  A61B5/22 ,  A61B5/24 ,  A61B5/389

CPC classification number: A61B5/4519 ,  A61B5/1123 ,  A61B5/1121 ,  A61B5/4842 ,  A61B5/4571 ,  A61B5/7246 ,  A61B5/4585 ,  A61B5/4595 ,  A61B5/4576 ,  A61B5/458 ,  A61B5/459 ,  A61B5/4848 ,  A61B5/14546 ,  A61B5/224 ,  A61B5/14542 ,  A61B5/24 ,  A61B5/389

Abstract: Methods for evaluating subjects having conditions associated with loss of muscle function (e.g., a motor neuron disease, a neuromuscular disease, or a myopathy) by measuring muscle function (e.g., muscle strength) are disclosed.